For citations:
Karpov A.A., Vaulina D.D., Mikhailova A.M., Smirnov S.S., Shilenko L.A., Anikin N.A., Chepurnoy Z.I., Vorotilov A.V., Stafeeva A.G., Bunenkov N.S., Ivkin D.Yu., Galagudza M.M. Study of the JAK inhibitors antifibrotic activity for the prevention and treatment of chronic thromboembolic pulmonary hypertension. Regional blood circulation and microcirculation. 2022;21(3):72-81. (In Russ.) https://doi.org/10.24884/1682-6655-2022-21-3-72-81